Comparison of natural killer and natural cytotoxic cells: characteristics, regulation, and mechanism of action. 1986

J R Ortaldo

NK cells are distinct cell populations that can be defined by a series of functional and surface characteristics. The existence of the discrete morphological counterpart for the NK cell, the LGL, has made it particularly convenient for categorizing these effector cells and distinguishing them from a variety of other effector cells. In addition, similar to T cells, considerable diversity exists among the NK cells. The diversity is seen not only in the expression of different surface markers but also within the specificity of target recognition as well as the secretory ability of LGL. It remains possible that much or even all of the heterogeneity that is seen in the phenotype and the function of LGL is due to differences and phases of activation and/or differentiation of these cells. Such differentiation-dependent, non-clonal, heterogeneity appears to account for the heterogeneity seen in subsets of monocytes and macrophages which can be detected in the expression of Ia antigen and Fc gamma receptors on activated macrophages. NK activity is highly regulated by IFNs (alpha, beta) and IL-2. Since NK cells also produce these factors, an autocrine regulation of these cells or their activity may occur. In addition, the mechanism of NK lysis is not yet clearly defined, but seems to involve cytotoxic molecules present in cytoplasmic granules that are released in various forms after effector-target cell contact. In contrast, NC activity against the WEHI-164 target cells appears to be a cytokine-mediated phenomenon, apparently mediated by the release of TNF during the course of the cytotoxicity assay. The mediation of NC activity by the release of TNF may account for the usual requirement for prolonged incubation periods to demonstrate this activity, in contrast to the rapid kinetics of NK activity. The association of TNF with NC activity also provides new clues about the nature of the NC cell, since TNF has been found to be produced predominantly by macrophages but can also be released by lymphocytes.

UI MeSH Term Description Entries
D007157 Immunologic Surveillance The theory that T-cells monitor cell surfaces and detect structural changes in the plasma membrane and/or surface antigens of virally or neoplastically transformed cells. Surveillance, Immunologic,Immunological Surveillance,Immunologic Surveillances,Immunological Surveillances,Surveillance, Immunological,Surveillances, Immunologic,Surveillances, Immunological
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

J R Ortaldo
April 1985, Biulleten' eksperimental'noi biologii i meditsiny,
J R Ortaldo
August 1979, Australian and New Zealand journal of medicine,
J R Ortaldo
January 2021, ACS biomaterials science & engineering,
J R Ortaldo
January 1987, Advances in experimental medicine and biology,
J R Ortaldo
October 1983, Biulleten' eksperimental'noi biologii i meditsiny,
Copied contents to your clipboard!